on September 16, 2004
Published online before print September 16, 2004, doi: 10.1161/01.ATV.0000145573.36113.8a
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 4, 2003
Accepted on September 9, 2004
Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions. Role of Activated Macrophages and Cytokines
N. Kalinina ;
From the Baker Heart Research Institute (N.K., A.A., G.D., P.K., G.K., A.B.), Alfred Hospital, Melbourne, Australia; and the Institute of Experimental Cardiology (N.K., Y.A., O.I., E.T.), Cardiology Research Complex, Moscow, Russia.
* To whom correspondence should be addressed. E-mail: alex.bobik{at}baker.edu.au.
Objective--Atherosclerosis is a chronic inflammatory response of the arterial wall to injury. High-mobility group box 1 (HMGB1) is an nDNA-binding protein, which on release from cells exhibits potent inflammatory actions. We examined its expression in atherosclerotic lesions and regulation by cytokines.
Methods and Results--In atherosclerotic lesions, HMGB1 protein is expressed by endothelial cells, some intimal smooth muscle cells, and macrophages. As atherosclerosis develops and progresses from fatty streaks to fibrofatty lesion, the number of HMGB1-producing macrophages increases markedly. Studies using the THP-1 cell line indicated that HMGB1 mRNA expression could be markedly upregulated by inflammatory cytokines, interferon (IFN)-
, tumor necrosis factor (TNF)-
and also transforming growth factor (TGF)-
. IFN-, TNF-, TWEAK, and TGF- induced an intracellular redistribution of HMGB1 and stimulated secretion by THP-1 cells and human blood monocytes. Inhibitors of MEK1/MEK2, protein kinase C, and PI-3/Akt, which inhibit lysosomal degranulation and mRNA translation, attenuated cytokine-induced HMGB1 secretion.
Conclusions--Macrophage is the major cell type responsible for HMGB1 production in human atherosclerotic lesions. Inflammatory cytokines and TGF- increase HMGB1 expression and secretion by monocyte/macrophages. HMGB1 appears to be a common mediator of inflammation induced by inflammatory cytokines and is likely to contribute to lesion progression and chronic inflammation.
Key words: high-mobility group box 1 • macrophages • cytokines • inflammation • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  T. Chen, Z. Huang, L. Wang, Y. Wang, F. Wu, S. Meng, and C. Wang MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages Cardiovasc Res, July 1, 2009; 83(1): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ito, K.-i. Kawahara, K. Okamoto, S. Yamada, M. Yasuda, H. Imaizumi, Y. Nawa, X. Meng, B. Shrestha, T. Hashiguchi, et al. Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin Complexes Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1825 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. H. Williams and H. E. Ireland Sensing danger--Hsp72 and HMGB1 as candidate signals J. Leukoc. Biol., March 1, 2008; 83(3): 489 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wahamaa, T. Vallerskog, S. Qin, C. Lunderius, G. LaRosa, U. Andersson, and H. E. Harris HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay J. Leukoc. Biol., January 1, 2007; 81(1): 129 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Porto, R. Palumbo, M. Pieroni, G. Aprigliano, R. Chiesa, F. Sanvito, A. Maseri, and M. E. Bianchi Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein FASEB J, December 1, 2006; 20(14): 2565 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jaulmes, S. Thierry, B. Janvier, M. Raymondjean, and V. Marechal Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1{beta} FASEB J, August 1, 2006; 20(10): 1727 - 1729. [Abstract] [Full Text] [PDF]
|
|